Benjamin Joseph Hollas, DO | |
14300 Orchard Pkwy, Westminster, CO 80023-9206 | |
(303) 430-5560 | |
(303) 430-5565 |
Full Name | Benjamin Joseph Hollas |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 14300 Orchard Pkwy, Westminster, Colorado |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053008086 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | TL.0009641 (Colorado) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Benjamin Joseph Hollas, DO 4521 Booth St, Kansas City, KS 66103-3420 Ph: (903) 452-8583 | Benjamin Joseph Hollas, DO 14300 Orchard Pkwy, Westminster, CO 80023-9206 Ph: (303) 430-5560 |
News Archive
For parents around the U.S., the mass school shooting in Connecticut fueled fears about how to ensure the safety of their own children. But for parents like [Elizabeth] Guzman, the tragedy affected them in a different and terrifying way, as they saw signs of their children in the shooter.
Weikang Bio-Technology Group Co., Inc., a leading developer, manufacturer and marketer of Traditional Chinese Medicine (TCM), Western prescription and OTC pharmaceuticals and other health and nutritional products in the People's Republic of China, today announced that the Company is reiterating its fiscal 2010 revenue guidance of $55 million, net profit of $21 million and earning per share of $0.75.
Many children with Crohn's disease and ulcerative colitis who received treatment through ImproveCareNow, a national quality improvement and research network, ceased to have symptoms and no longer needed to take steroids for disease management.
Clinicians are missing golden opportunities to identify heart disease before patients start displaying symptoms, according to a study of 13,877 people published in the May issue of UK-based IJCP, the International Journal of Clinical Practice.
› Verified 6 days ago